NexPoint Life Sciences III DST

An investment in NexPoint Life Sciences III DST is highly speculative, illiquid and involves substantial risk including the potential loss of your entire investment. The photos presented in this material are of the actual Property that are part of the Offering.

There are substantial risks in any investment program. This is not an offer to sell securities or a solicitation of an offer to buy securities.  An offer to sell interests(“Interests”) in NexPoint Life Sciences III DST (the “Trust”) may be made only pursuant to the Private Placement Memorandum of the Trust, as supplemented (the “PPM”), which is available upon request. Distributions are not guaranteed. Please review the entire PPM prior to investing. Reference is made to the PPM for a statement of risks and terms of the Offering. The information set forth herein is qualified in its entirety by the PPM. All potential investors must read the PPM and no person may invest without acknowledging receipt and complete review of the PPM. The offering of Interests (the “Offering”) is being made by means of the PPM only to accredited investors who meet minimum accreditation requirements, as well as suitability standards as determined by a qualified broker-dealer or investment advisor. The contents of this communication may not be relied upon in making an investment decision related to this Offering.  All prospective investors must read the PPM, including the “Risk Factors,” including fees and expenses and other pertinent information prior to investing.  These investment opportunities have not been registered under the Securities Act of 1933 and are being offered pursuant to an exemption therefrom and from applicable state securities laws.

An investment in an Interest is highly speculative and involves substantial risks including, but not limited to:

this is a “best-efforts” offering with no minimum raise or minimum escrow requirements;
the lack of liquidity and/or public market for the Interests;
the holding of a beneficial interest in the Trust with no voting rights with respect to the management or operations of the Trust or in connection with the sale of the Property;
risks associated with owning, financing, operating and leasing a medical device research and development facility, and real estate generally, in Minnesota, and more specifically the Minneapolis MSA;
the Tenant is engaged in the business of medical device research and development which is a highly competitive business characterized by rapidly evolving technology and thus the Tenant’s financial instability will materially and adversely affect the Master Tenant’s and the Trust’s operations;
risks associated with the impact of pandemics, including the COVID-19 pandemic, on the Property and the economies of the community in which the Property exists;
under the Tenant Lease, the Tenant is allowed to make certain permitted alterations to the Property which could adversely affect the Master Tenant’s ability to re-tenant the Property to a new tenant;
the Property is highly specific to the Tenant’s medical device research and development operations, which may adversely affect the Master Tenant’s ability to re-tenant the Property;
the Trust depends on the Master Tenant for revenue, and the Master Tenant depends on the Tenant for revenue and thus any default by the Master Tenant or the Tenant will adversely affect the Trust’s operations;
performance of the Master Tenant under the Master Lease;
reliance on the Master Tenant to manage the Property;
risks associated with the Master Tenant’s finances, including its limited capital, limited operating history, and the Demand Note that capitalizes the Master Tenant;
risks relating to the terms of the financing for the Property, including the use of leverage;
the existence of various conflicts of interest among the Sponsor (“NexPoint Real Estate Advisors IV L.P”), the Trust, the Master Tenant, the Asset Manager, and their affiliates;
material tax risks, including treatment of the Interests for purposes of Code Section 1031 and the use of exchange funds to pay acquisition costs, which may result in taxable boot;
the Interests not being registered with the Securities and Exchange Commission the SEC or any state securities commissions;
risks relating to the costs of compliance with laws, rules and regulations applicable to the Property;
risks related to competition from properties similar to and near the Property; and
lack of diversity of investment as to type of asset or geographic location.
NexPoint Securities, Inc., an entity under common control with the Sponsor, serves as the Managing Broker-Dealer of the Offering.
The Managing Broker-Dealer was formed in November 2013 and is registered as a broker-dealer with the SEC and is a member of FINRA/SIPC.

PLEASE CONTACT YOUR ADVISOR WITH ANY QUESTIONS ABOUT THIS OFFERING.